Synthetic polymeric sialoside inhibitors of influenza virus receptor-binding activity  by Matrosovich, M.N. et al.
Volume 272, number 1,2, 209-212 FEBS 08970 October 1990 
Synthetic polymeric sialoside inhibitors of influenza virus 
receptor-binding activity 
M.N. Matrosovich”, L.V. Mochaloval, V.P. Marininal, N.E. Byramova2 and N.V. Bovin2 
‘Institute of Poliomyelitis and Viral Encephalitides, USSR Academy of Medical Sciences, 142 782 Moscow Region, USSR and 
=Shemyakin Institute of Bioorganic Chemistry, USSR Academy of Sciences, 117 871 Moscow, Miklukho-Maklaya 16/10, USSR 
Received 13 August 1990 
Anomeric aminobenzylglycosides of NeuSAc were coupled with the polyacrylate carrier and a number of synthetic polyvalent sialosides obtained 
were investigated as inhibitors of influenza virus attachment. The inhibitory activity of polymeric sialosides is highly dependent upon the NeuSAc 
residue content and the nature of the carrier. The polyacrylic acid based polymer bearing 10 molcp, of NeuSAc is 3 orders of magnitude more potent 
inhibitor than the corresponding monovalent benzylsialoside and considerably more active than fetuin. 
Influenza virus; Virus at~c~ent inhibitor; Inhibitor of hema~lutination; Sialic acid Fetuin; Antiviral drug 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Influenza virus infection is initiated by the specific at- 
tachment of virus to the cellular receptors mediated by 
the viral HA; the RBS of HA recognizes sialic acid 
residues of the host cell glycoproteins or glycolipids 
(reviewed in (1,2]). 
2.1. materials 
Hemagglutination and in some cases infection by in- 
fluenza viruses could be inhibited by natural sialylgly- 
coproteins [l-3]. Some low molecular mass sialic acid 
derivatives have been tested [3-51, but their inhibitory 
activity was too low to be of practical interest. Con- 
sidering the multivalent cooperative nature of the 
virus-cell interaction, some authors supposed that the 
development of potent artificial inhibitors of influenza 
virus attachment must include the design of polyvalent 
structures [6-g]. Roy et al. [lo] reported protein con- 
jugates with NeuSAc to be active in HA1 test. Totally 
synthetic polymers containing NeuSAc were also ob- 
tained [ll], but nothing was reported on their in- 
hibitory activity. 
The synthesis of monosialosides (Table IA) will be described 
elsewhere (Byramova et al.). Poly(4-nitrophenylacrylate) was a gift 
from Dr A.E. Ivanov (Shemyakin Institute of Bioorganic Chemistry). 
SAaZ,bLac, Twin-80, HPR were obtained from Serva, bovine fetuin 
from Fluka. All the other reagents were of analytical grade. Buffers: 
PBS = 0.14 M NaCl, 0.01 M sodium phosphate, pH 7.3; PBST = 
PBS containing 0.01% Twin-80. 
2.2. Viruses 
Seed stocks of influenza viruses were obtained from the Virus Col- 
lection of the Ivanovsky Institute of Virology, Moscow. Viruses were 
grown in 9-day-old embryonated chicken eggs and purified by sucrose 
density gradient centrifugation 1121. 
2.3. Synthesis of polymeric sia~osides 
We have synthesized water-soluble polymers differ- 
ing in NeuSAc content and demonstrated the existence 
of the sharp optimum for NeuSAc density on the carrier 
to reveal maximal inhibition of the influenza virus 
receptor-binding activity. 
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3.5 rmol SAo(@)GAB in 200 ~1 of DMF were mixed with 70 ~1 of 
10% solution of poly(4nitrophenylacrylate) in DMF (35 pmol with 
respect to monomeric units). 20 ~1 of triethylamine were then added 
and the mixture was kept at 20°C for 48-60 h until monovalent 
sialoside depletion as judged by TLC. The resulting copolymer was 
further modified by addition of 2 ml of either 0.1 N aqueous NaOH 
or 10% ethanoI~ine in DMF: 48-72 h later 4-nitrophenol was 
removed by gel-filtration on Sephadex LH-20 column (1 x25 cm; 
MeCN/HrO, 1:l). In the first case the copolymers designated as 
P, 10.1 or P~.Io.~, in the second as Pa.r0.2 (Table 1B) were obtained 
with 8590% yield. To obtain Pu.~.i, Pa.20.r and Pa.30 I (Table lB), 
3.5 pmol of SAolGAB in 200 ~1 of DMF were mixed with 140,35, or 
23 ~1 of 10% poly(4-nitrophenylac~late) in DMF, respectively, the 
unreacted groups being hydrofyzed by NaOH. A control polymer, 
polyacryl(2-hydroxyethyl)amide (P), was obtained by treatment of 14 
mg of poly(4nitrophenylacrylate) with 2 ml of 10% ethanolamine in 
DMF. Its average molecular mass determined by gel-filtration using 
dextrans as standards was approximately 100 kDa. 
Abbreviation: FBI, fetuin-bin~ng inhibition; HA, hema~utinin; 
HAL hema~lutination inhibition; HRP, horseradish peroxidase; 
NeuSAc, 5-N-acetylneuraminic acid; RBS, receptor-binding site; 
SAa2,6Lac, cr2,6 sialyllactose 
The SAor@)GAB content in polymeric sialosides was assessed spec- 
trophotometrically at 248 nm using SACYAAB as a standard. 
2.4. HemaggIutinatton i hibition assay 
HA1 test was carried out by the microtiter method [12] using PBS 
as a diluent. 
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Table I 
Mono- (A) and polyvalent (B) sialosides studied 
(A) Common formula R Designation 
NeuSAco(or ~)Z+GCH&,%NH-R COCHs 
COCHzNHCOOC(CHs)s 
COCHzNHz 
SAor(or @AAB 
SAa(or P)BGAB 
SAo(or fl)GAB 
(B) Common formula X Mole fraction 
of NeuSAc (Vo) 
Y Designation 
-[-CHr-CH-1. -CH2-CH- 
I 1 
c=o c=o 
I I 
Y X 
SAoGAB 
SAoGAB 
SAPGAB 
SAaGAB 
SAaGAB 
SACYGAB 
NH(CH&zOH 
s ONa PC&S.1 
10 ONa PC&o I
10 ONa PB.10.1 
10 NH(CH2)zOH Pa.lO.2 
20 ONa P, 20 1 
30 ONa P cl 30 1 
0 NH(CH&OH P 
2.5. Fetuin-binding inhibition assay 
FBI test (A.S. Gambaryan and M.N. Matrosovich, in preparation) 
was carried out as follows. Fetuin-HRP conjugate was synthesized by 
the periodate method [13]. The microtiter plate wells (Linbro, Flow, 
USA) were coated with 100 ~1 of fetuin solution (10 Fg/ml) in PBS at 
4OC overnight. The plate was washed with PBST, water and air-dried. 
The virus (0.2 cg) in 100 ~1 of PBST was allowed to bind to the im- 
mobilized fetuin for 2 h at 4°C then the plate was washed with PBST. 
The PBS-dissolved inhibitors in various concentrations or PBS alone 
(50 1;1) were added for 10 min followed by 50 pl of fetuin-HRP con- 
jugate (1 pglml in respect o fetuin). After incubation for 2 h at 4’C 
the plate was washed, filled with ~phenylen~amine and further 
operations were carried out as usual. 
3. RESULTS AND DISCUSSION 
To produce potent artificial influenza virus attach- 
ment inhibitors, pol~alent sialic acid-containing 
macromolecules were synthesized. 
Pritchett et al. [4] showed NeuSAc cY-benzylglycoside 
to be the most potent inhibitor of A/Memphis/102/72 
(H3N2) influenza virus adsorption to erythrocytes 
among a number of synthetic monovalent sialosides ex- 
amined. Taking this into account and intending to bind 
NeuSAc residues to the polymeric carrier, aminoben- 
zylglycosides of NeuSAc (Table 1A) were synthesized. 
Polyvalent sialosides were obtained by condensation of 
SAaGAB or SAPGAB with poly(4nitrophenylacrylate) 
followed by modification of the resulting polymer with 
aqueous alkali or ethanolamine (Table 1B). 
The studies on inhibitors of influenza virus attach- 
ment are usually based on an assessment of their ability 
to block virus-mediated hemagglutination or adsorp- 
tion of the virus to erythrocytes (2-4,9], but 
monovalent sialosides were found to compete poorly 
with red blood cells for virus binding [4]. To compare 
relative inhibitory activity of mono- and polyvalent 
sialosides, an alternative assay has been explored here. 
This solid-phase enzyme-linked assay is based on the 
competition for specific binding by the viral HA be- 
tween the sialoside under study and si~ylglycoprotein 
fetuin labeled with HPR. 
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The competition curves (Fig. 1) show that binding of 
the fetuin conjugate by the A/Bangkok/l/79 (H3N2) 
virus could be totally inhibited by monovalent 
SAaAAB, SAcvBGAB and their polymeric analogs. @- 
Anomers SA&AAB and SAOBGAB, corresponding to 
polymer Pp.lo.l, and polymer carrier alone (P; see Table 
II) are inactive. These results indicate that binding of 
fetuin-HRP to the immobilized virus is specifically in- 
hibited by mono- and polyvalent cY-benzylglycosides of 
NeuSAc. 
The activity of substances tested has been expressed 
as the concentration of sialic acid residues required to 
inhibit fetuin-HRP binding to virus by 50%. Compar- 
ing a number of mono- and polyvalent inhibitors (Table 
II), we came to the following conclusions. Monovalent 
sialosides SAatAAB and SAatBGAB are approximately 
5-fold more active inhibitors of BK/79 and TX/77 
(H3N2) influenza viruses than SAo2,6Lac in accor- 
dance with the data of Pritchett et al. [4]. The coupling 
of the monovalent receptor analog with the polymeric 
carrier increases markedly its ability to block viral 
1 10 lo2 lo3 
Concentration of Neu5Ac CPM) 
Fig. 1. Inhibition of the A/Bangkok/l/79 binding of the fetuin con- 
jugate by SAcu2,6Lac (X), SAcrAAB (a), SAoBGAB (Oh 
SABBGAB (CR), Pa.to I (O), P,.r t (A), P,.Ic i (oh pe.zo 1 (A), 
P, 30.1 (=). 
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Table II 
Inhibition of A/Bangkok/l/79 (BK/79) and A/Texas/l/77 (TX/77) by synthetic and natural sialosides 
FBI test HA1 test 
Concentration for 50% inhibition’ Relative potencyb Minimum concentration for HAP 
BK/79 TX/77 BK/79 TX/77 BK/79 TX/77 
SAar2,6Lac 2100 1500 0.2 0.2 NDC ND 
SAolAAB 450 3bo 1 1 ND ND 
SAC&GAB 470 310 1 1 ND ND 
Pa 10.2 141 4.5 3.3 70 >4OOd >4OOd 
PlYS.1 31 10.4 15 30 > 1oOd 1OOd 
pca.10.1 0.23 0.23 2 040 1350 1.8 (2.5) 3.6 (4.8) 
P,.ZO.l 0.6 1.7 783 182 4.8 (4.4) 17 (16) 
P,.SO.l 5.8 (>9;; 81 84 32 (24) 167 (125) 
P ( > 9OO)d (> 250)d (> 250)d 
Fetuin 7 14 67 22 lo(51) 49(250) 
acrM NeuSAc (values in parentheses represent weight concentration in Fg/ml) bInhibitory potency in respect o SAolBGAB ‘ND = not determined 
dThere was no inhibition at the highest concentration used 
receptor-binding activity, Por.s.r being 1%30-fold, and corresponding polyvalent sialoside Pu.io.r in both FBI 
Pa.ro.r being 3 orders of magnitude more active in- and HA1 tests inhibits only H3 subtype human influen- 
hibitors of BK/79 and TX/77 viruses than monovalent za A viruses BK/79, TX/77, A/Aichi/2/68, A/Philip- 
sialosides. Most likely, Pol.r~.r has an optimal composi- pines/ 2/82, while being inactive as inhibitors of avian 
tion for interaction with the multivalent viral HA, since H3 subtype virus A/duck/Ukraine/63 and all the other 
an additional increase of the NeuSAc residue content in A and B viruses studied (A/Chile/ l/83, 
the polymers (P,.zo.I and especially P,.30.1) lowered in- A/Taiwan/l/86 (HI), A/Singapore/l/57 (H2), 
hibitory activity substantially. It should be clarified B/LeeNO, B/Hong Kong/8/73 and B/USSR/100/83; 
whether the linear distance between the neighboring data not shown). It seems that NeuSAc (Y- 
NeuSAc residues, the distinctions in the shape of benzylglycosides mimic the NeuSAcar2,6Gal receptor 
polymeric sialosides differing on NeuSAc density, or determinants, recognized by human H3 subtype viruses 
other factors play a crucial role in the observed effect. [1,21. 
The influence of the macromolecular carrier on the 
inhibitory activity is demonstrated by comparison of 
Pu.ro.l and Pa.i0.2 polymers with the same NeuSAc con- 
tent. The activity of P,. 10. I bearing ionizable - COOH 
residues against TX/77 and BK/79, respectively, is 20- 
and lOOO-fold higher than that for Pa.10.2 which con- 
tains - CONHCHzCHzOH moieties. The higher activi- 
ty of Pu.ro.i polysialoside may be caused by the imita- 
tion with polyanionic carrier of negatively charged cell 
membrane, or by the higher conformational rigidity of 
the charged polymer macromolecule. 
In the present study, a new principle of designing ar- 
tificial influenza virus attachment inhibitors has been 
evaluated. The results obtained may be interesting in 
the development of inhibitors of influenza virus infec- 
tion. 
The relative potency of polyvalent inhibitors in the 
FBI test correlates with their activity in the HA1 assay 
(Table II). Pu.ro.i, the most potent inhibitor synthesiz- 
ed, blocks hemagglutination of BK/79 and TX/77, 
respectively, 6 and 13 times stronger than fetuin (20 and 
50, respectively, if the weight concentrations of both in- 
hibitors are compared). As far as we know, this is the 
first example of a totally synthetic and comparatively 
potent inhibitor of influenza virus-mediated hemag- 
glutination. 
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